PHAR vs CRMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

PHAR

35.9
AI Score
VS
CRMD Wins

CRMD

36.8
AI Score

Investment Advisor Scores

PHAR

36score
Recommendation
SELL

CRMD

37score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric PHAR CRMD Winner
Forward P/E 277.7778 15.7729 CRMD
PEG Ratio 0 0 Tie
Revenue Growth -3.2% 156.5% CRMD
Earnings Growth -62.9% 6.7% CRMD
Tradestie Score 35.9/100 36.8/100 CRMD
Profit Margin 2.5% 40.5% CRMD
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

PHAR 1M: -10.0% · 3M: -7.5% CRMD 1M: +1.9% · 3M: +1.7%

Current Technical Phase

PHAR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.6 · Price: $11.85

CRMD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 54.9 · Price: $8.20

Fundamentals Snapshot

Metric PHAR CRMD
Market Cap
Forward P/E 38.1 136.7
Trailing P/E 84.6 3.9
Revenue (TTM)
Revenue Growth 0.0% 1.6%
Gross Margin 0.9% 0.9%
Operating Margin 0.0% 0.4%
EPS 0.14 2.11
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CRMD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.